Dr. Kristen Maria Bish, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 9730 Dorchester Rd Unit 206, Summerville, SC 29485 Phone: 843-594-3032 Fax: 843-285-5921 |
Ms. Jennifer Candace Bonner, MS Audiologist Medicare: Not Enrolled in Medicare Practice Location: 107 W 5th North St, Summerville, SC 29483 Phone: 843-871-9669 |
Hearing Care Of Summerville Audiologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 2nd North St Unit A, Summerville, SC 29483 Phone: 843-871-9669 Fax: 843-871-8197 |
Connect Hearing, Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1801 Old Trolley Rd Ste 101, Summerville, SC 29485 Phone: 843-871-3235 Fax: 843-871-3233 |
Dr. Elizabeth C Alberto, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 2nd North St, Summerville, SC 29483 Phone: 843-871-9669 Fax: 843-871-8197 |
Ms. Janet M Petitte, MS CCC/A Audiologist Medicare: Medicare Enrolled Practice Location: 1801 Old Trolley Rd Ste 101, Summerville, SC 29485 Phone: 843-871-3235 Fax: 843-871-3233 |
Hearing Care Of Summerville Audiologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 2nd North St, Summerville, SC 29483 Phone: 843-871-9669 Fax: 843-871-8197 |
Mr. Charles L. Whitfield Jr., AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 208a East 2nd North St., Summerville, SC 29483 Phone: 843-871-9669 Fax: 843-871-8197 |
Dr. Kevin James Still, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 102 W 8th North St Ste F, Summerville, SC 29483 Phone: 843-261-7746 |
News Archive
Fewer than 1 in 10 adult Canadians is in ideal cardiovascular health, according to the new CANHEART health index developed to measure heart health published in CMAJ (Canadian Medical Association Journal).
A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
A new study published today in the journal Cell Reports by scientists at the German Cancer Research Center (DKFZ) shows that the direction taken by a cancer cell depends on the configuration of the cell itself as well as the activation of a universal cancer cell receptor called CD95.
› Verified 8 days ago